Get startedLog in
    Picture of Cohance Lifesciences logo

    COHANCE — Cohance Lifesciences News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    All News

    Brief: Suven Pharmaceuticals March-Qtr Consol Net Profit Rises

    Picture of Cohance Lifesciences logoCohance Lifesciences
    09/05/2022 08:42
    May 9 (Reuters) - Suven Pharmaceuticals Ltd  SUVH.NS :
    * SUVEN PHARMACEUTICALS - DECLARED INTERIM DIVIDEND OF 1 RUPEE
    * SUVEN PHARMACEUTICALS LTD -MARCH QUARTER CONSOL NET PROFIT 916.7 MILLION RUPEES VERSUS
831.2
MILLION RUPEES YEAR AGO
    * SUVEN PHARMACEUTICALS LTD  MARCH-QUARTER  CONSOL REVENUE FROM OPERATIONS 3.64 BILLION
RUPEES
VERSUS 2.59 BILLION RUPEES YEAR AGO

Source text for Eikon:  ID:nBSE5hbj5h 
Further company coverage:  SUVH.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Cohance Lifesciences

    See all news